APPLICATIONS PUBLISHED 21 APRIL 2004
Published: 1-Oct-2004
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Particles with improved solubilisation capacity
Lyotropic Therapeutics 1408932*
Sildenafil citrate chewing gum formulations and methods of using the same
WM Wrigley Jr Co 1408933*
Pharmaceutical compsn for prophylaxis and treatment of calcium metabolism disorders comprising clodronate in combination with glyceryl palmitostearate
SC Sindan 1408934*
Process for the preparation of medicated gums
ATP Avant-Garde Technologies & Products 1408935*
Pharmaceutical compsn
Henderson Morley Research & Development 1408936*
Use of antagonists or partial agonists of 5HT1A receptors for the preparation of a medicament for treatment and prevention of gastrointestinal diseases
Dinan, Timothy Gerard 1408937*
Therapeutic strategies for prevention and treatment of Alzheimer's disease
Isis Innovation 1408938*
Methods for preparation and use of 1 alpha,24(S)-dihydroxyvitamin D2
Bone Care International 1408939*
Pharmaceutical compsn comprising deramciclane for the treatment of the decline and/or damage of cognitive functions
Egis Gyogyszergyar 1408940*
Pharmaceutical compsn and method of using the same
Zetetic Research 1408941*
Methods and clinical devices for the inhibition or prevention of mammalian cell growth
Biointeractions 1408942*
Pharmaceutical formulation containing am LTB4 antagonist
Boehringer Ingelheim Pharma 1406943*
Erucamide compounds for the treatment and prevention to disturbances of the secretory system
Hamberger, Anders; Stenhagen, Gunnar 1406944*
Methods, compounds, and compsns for reducing body fat and modulating fatty acid metabolism
Regents of the University of California 1406945*
Histone deacetylase inhibitors
Circagen Pharmaceutical 1406946*
Fumaric acid derivatives as NF-kappaB inhibitors
Fumapharm 1406947*
Thyroid therapeutic agent
Berlin-Chemie Aktiengesellschaft 1406948*
Gycine betaine and its use as anti-haemorrhagic agent
Messadeck, Jallal 1408949*
Methods of treating cytokine mediated diseases
Boehringer Ingelheim Pharmaceuticals 1408950*
Anti-inflammatory fatty alcohols and fatty acid esters useful as antigen carriers
Yeda Research and development 1408951*
Naphthaquinone derivatives as inhibitors of tau aggregation for the treatment of Alzheimer's and related neurodegenerative disorders
The University Court of the University of Aberdeen 1408952*
Carbamate compounds for use in preventing or treating bipolar disorder
Ortho-McNeil Pharmaceutical 1408953*
Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
Ortho-McNeil Pharmaceutical 1408954*
Novel metallotexaphydrin derivatives
Pharmacyclics 1408955*
Uses of metal salts to stabilise taxane-based compsns
Baker Norton Pharmaceuticals 1408956*
Triptolide prodrugs having high aqueous stability
Pharmagenesis 1408957*
Benzofuranes and their use in the treatment of atrial fibrillation
Karo Bio 1408958*
Use of Galilella lactone
Institut fuer Biotechnologie und Wirkstoff-Forschung 1408959*
benz-Indole and benzo-quinoline derivatives as prodrugs for tumour treatment
The School of Pharmacy, University of London 1408960*
2-pyrrolidone derivatives as prostanoid agonists
F Hoffmann-La Roche 1408961*
Substituted isoindoles and the use thereof
Bayer Healthcare 1408962*
2-5-(5-carbamimidoyl-1 H-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor VIIA inhibitors
Axys Pharmaceuticals 1408963*
Novel use of 2-5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts
Merck 1408964*
Use of dual H3/H2 antagonists with a bipiperadinic structure in the treatment of cognition deficit disorders
Schering 1408965*
A synergistic pharmaceutical combination for the prevention or treatment of diabetes
N-Gene Research Laboratories 1408966*
Novel pharmaceutical compsns based anticholinergic agents, corticosteroids and betamimetic agents for the treatment of inflammatory and/or obstructive respiratory tract diseases
Boehringer Ingelheim 1408967*
Receptor-adapted nicotine withdrawal by anti-cholinergic and antinoradrenergic blockade
Kox, Wolfgang; Hensel, Mario 1408968*
Use of chelators in the treatment of macular degenerative disease
Xilinas, Michel 1408969*
Indolines and tetrahydroquinolines as prodrugs for tumour treatment
The School of Pharmacy, University of London 1408970*
Novel quinolines and uses thereof
Ariad Pharmaceuticals 1408971*
Methods and treatment of cancer with irinotecan based on MDR1
Epidauros Biotechnologie 1408972*
Means and methods for improved treatment of cancer based on MRP1
Epidauros Biotechnologie 1408973*
Methods for the treatment of cancer based on irinotecan based on UGT1A1
Epidauros Biotechnologie 1408974*
Methods for the treatment of cancer with irinotecan based on CYP3A5
Epidauros Biotechnologie 1408975*
Treatment for attention-deficit hyperactivity disorder
Psychogenics 1408976*
A combination therapy for the treatment of heart failure
Orion Corp 1408977*
Novel phenylamino-pyrimidines and uses thereof
Ariad Pharmaceuticals 1408978*
R-6-hydroxy-buspirone
Bristol-Myers Squibb 1408979*
Novel quinazolines and uses thereof
Ariad Pharmaceuticals 1408980*
Methods for preventing antipsychotic-induced weight gain
Corcept Therapeutics 1408981*
Pharmaceutical compsns for treatment of digestive disorders and associated diseases
Feher, Janos 1408982*
Method of treating hyperproliferative diseases using active vitamin D analogues
Bone Care International 1408983*
Organo-phosphorus compounds for activating gamma/delta T cells
BioAgency 1408984*
Novel phosphopyrimidones and uses thereof
Ariad Pharmaceuticals 1408985*
Proteomimetic compounds and methods
Yale University 1408986*
Tetracycline compounds having target therapeutic activities
Paratek Pharmaceuticals 1408987*
Compsns for orally administered nutritional supplements to repair articular cartilage
Medere, Shawn 1408988*
Method and material for treating immune diseases
Glycogenesis 1408989*
Use of hyaluronic acid uronides for the treatment of inflammatory processes
Hans-Knoell-Institut fuer Naturstoff-Forschung 1408990*
Nasal spray having Dead Sea salts
Cordray, Scott 1408991*
Pharmaceutical compsn for treating hypercholesteroaemia
SK Enterprise 1408992*
Halogen compounds for use in medicine
Chapman, Robert Edward; Chapman, Robert Peter 1408993*
Chemically stabilised chlorite solutions for treating cancer
OCO Chemie 1408994*
Modulating serum amyloid A interaction with tanis and agents useful for same
Autogen Research 1408995*
A simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome or polyplex for systemic administration of a therapeutic or diagnostic agent
Georgetown University 1408996*
Kefir extract as an anti-cancer agent
McGill University 1408997*
Kefir as a potent anti-oxidant compsn
McGill University 1408998*
Compsns addressing inflammation and/or degenerative disorders
Bomac Laboratories 1408999*
Use of Agaricus Blazei murill to prevent or treat skin and other disorders
Atlas World 1409000*
Mineral-protein preparations (MPP) and neuropathies in diabetes
Basic, Robert 1409001*
Spheroids based on plant extract adsorbates and method for preparing same
Societe Civile d'Inventeurs Apis Spheromont 1409002*
Methods for reducing immunogenicity of polypeptides
Merck Patent 1409003*
Isolated human RAS-like proteins, nucleic acid molecules encoding these human RAS-like proteins, and uses thereof
PE Corp 1409004*
Modulators of notch signalling for use in immunotherapy
Lorantis 1409005*
Method of treating diabetes mellitus
Nobex Corp 1409006*
Pharmaceutical compsns which inhibit vascular proliferation and method of use thereof
Societe de Conseils de Recherche et d'Applications Scientifiques 1409007*
Use of the disintegrin domain of an adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent
Institut National de la Sante et de la Recherche Medicale (INSERM) 1409008*
Therapeutical vaccination
Nordic Vaccine Technology 1409009*
Treating endotoxaemia and related disorders with probiotics
Probendo 1409010*
Prime-boost vaccination strategy
Alfred Hospital; Commonwealth Scientific and Industrial Research Organisation; The University of Melbourne 1409011*
Methods of inducing a cytotoxic immune response and recombinant simian adenovirus compsns useful therein
The Wistar Institute of Anatomy and Biology 1409012*
